Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis

Cancer Res. 1997 Jun 1;57(11):2137-9.

Abstract

The nucleus has been shown to be a site for the inositol lipid cycle that can be affected by treatment of quiescent cells with growth factors such as insulin-like growth factor I (IGF-I). Indeed, the exposure of Swiss 3T3 cells to IGF-I results in a rapid and transient increase in nuclear phospholipase C (PLC) beta1 activity. In addition, several other reports have shown the involvement of PLC beta1 in nuclear signaling in different cell types. Although the demonstration of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate hydrolysis by nuclear PLC beta1 established the existence of nuclear PLC signaling, the significance of this autonomous pathway in the nucleus has yet to be thoroughly clarified. By inducing both the inhibition of PLC beta1 expression by antisense RNA and its overexpression, we show that this nuclear PLC is essential for the onset of DNA synthesis following IGF-I stimulation of quiescent Swiss 3T3 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Animals
  • Blotting, Western
  • Cell Nucleus / metabolism*
  • Cells, Cultured
  • Cloning, Molecular
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic
  • Insulin-Like Growth Factor I / pharmacology*
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Isoenzymes / physiology*
  • Mice
  • Phospholipase C beta
  • RNA, Antisense
  • Signal Transduction / physiology*
  • Transfection
  • Type C Phospholipases / genetics
  • Type C Phospholipases / metabolism
  • Type C Phospholipases / physiology*

Substances

  • Isoenzymes
  • RNA, Antisense
  • Insulin-Like Growth Factor I
  • Type C Phospholipases
  • Phospholipase C beta
  • Plcb1 protein, mouse